Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.06 Aug 2009
White Papers
Focus Area: Drug Discovery
The L-Factor: "We’ve got the critical mass”
Franz Humer, a lawyer by training, is CEO of F. Hoffmann-La Roche Ltd – a company whose strategy is to use innovative scientific breakthroughs to shape the future of medicine.
Miniaturised and automated protein quantification for more efficient development of biotherapeutics
Gyros leads the world in compact disk (CD) microfluidic solutions for the life science industry, focusing on protein quantification within biotherapeutic discovery and development.
Executive Insight: LIMS
Talking with Dave Champagne, Vice President and General Manager, and Kim Shah, Director of Marketing and Business Development, for Informatics at Thermo Fisher Scientific.
Achieving GLP Compliance Through Deployment of LIMS
By Brigitte Staecker, Thermo Fisher Scientific
Combined competences and a common goal
Why research collaborations are increasingly important for the pharmaceutical and biopharma industry
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.